FLEMINGTON, N.J., March 24, 2020 /PRNewswire/ -- EmphyCorp Inc. www.EmphyCorp.com, a Private Corporation, specializes in Rx Non-Steroidal Nasal Spray Technology with no known si

ATLANTA, March 24, 2020 /PRNewswire/ -- The CDC Foundation today announced that Facebook is providing a 2-to-1 matching donation—up to $10 million—as part of the Foundation's Facebook Fundraiser aimed at generating support to help combat the coronavirus pandemic. This generous matching donation is targeted to encourage the Facebo

WASHINGTON, March 24, 2020 /PRNewswire/ -- As lawmakers hurry to finalize a legislative package responding to the coronavirus pandemic, the U.S. Conference of Mayors (USCM) is urging them to ensure a greater number of cities are eligible for federal resources. Under the legislation introduced in the House, only cities with populations of 500,000 or more are eligible for

PASADENA, Calif., March 24, 2020 /PRNewswire/ -- 

WASHINGTON, March 24, 2020 /PRNewswire/ -- Breaking research in AACC's The Journal of Applied Laboratory Medicine shows that the fentany

CAMBRIDGE, Mass., March 24, 2020 /PRNewswire/ -- To prevent hospitals from being overwhelmed, states should focus on preventing the spread of COVID-19 at high-risk sites, such as nursing homes, and in high-risk localities, the COVID-19 Policy Alliance—a group of experts brought together by two professors at the MIT Sloan School of Management—said in a present

SAN FRANCISCO, March 24, 2020 /PRNewswire/ -- Today Brightday announced that it is offering its normally subscription-based software to individuals for free for the duration of the COVID-1

NEW YORK, March 24, 2020 /PRNewswire/ -- Based on its successful initiative in China, Gerber Technology today announced the creation of the Gerber PPE Task Force and Resource Team to support their global customers and partners as they work to increase their production or transition to manufacturing personal protective equipmen

SILVER SPRING, Md., March 24, 2020 /PRNewswire/ -- As part of the U.S. Food and Drug Administration's ongoing commitment to combatting the coronavirus (COVID-19) pandemic and providing flexibility across FDA-regulated industries, the agency

ST. LOUIS, March 24, 2020 /PRNewswire/ -- DYNALABS and Mayo Clinic have joined forces to launch ANiGENT, a new company whose proprietary software uses machine learning to deliver a state-of-the-art drug diversion surveillance system. The novel platform will help hospitals and health systems reduce patient and worker harm from potential drug diversion and p